Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-27

Clinical Trial Update: Resuvastatin Treatment for Symptomatic Middle Cerebral Artery Stenosis Based on High-resolution Magnetic Resonance Imaging [Phase 4]

View source ↗

Summary

Phase 4 trial update examining resuvastatin for symptomatic intracranial arterial stenosis based on high-resolution MRI data; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resuvastatin (resuvastatin)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Intracranial Arterial Stenosis | Phase 4 | Status: COMPLETED